Analyst Ratings for Clovis Oncology (CLVS)

CLVS Rating Summary

CLVS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CLVS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $14.00 (+191.1%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/27/2020 SVB Leerink Andrew Berens Downgrade Underperform
(Market Perform)
5.00
(N/A)
9.03
(4.81)
-46.73% Details
4/9/2020 BofA Securities N/A Downgrade Underperform
(Neutral)
N/A
(N/A)
6.93
(4.81)
-30.59% Details
Like CLVS Ratings? Also take a look at CLOV, GSK, AZN, MRK

CLVS Ratings News